July 19, 2022
Legal Review: Medicare Program, 340B, and State Price Updates
6 Minute Read
July's market update is a legislative review of 340B contract pharmacy restrictions, new Medicare bills, and SPTR updates.
Blog
July 13, 2022
Top Trends in Specialty Network and Service Design
5 Minute Read
Benchmarks on specialty networks using our exclusive ICyte channel and patient access data: what specialty networks look like, who's included, and how network sizes vary by therapeutic category.
June 27, 2022
Pharma vs. 340B
4 Minute Read
This month’s market update features the latest news detailing the tumultuous relationship between pharma and 340B, including The Supreme Court, HRSA, and insight on how inflation escalates everything.
June 14, 2022
Top Trends in Contracting
6 Minute Read
Using exclusive ICyte Benchmarks from over 230 brands across more than 50 manufacturers, we examine the top trends in specialty pharmacy contracting.
June 7, 2022
Best Practices: Identifying and Avoiding Patient Access Barriers
4 Minute Read
Market access leaders from DBV Technologies, Sesen Bio, and Karyopharm Therapeutics discuss strategies to overcome obstacles to patient initiation and adherence.
May 26, 2022
The Nuance and Necessity of Timely State Price Transparency Reporting
4 Minute Read
Expert opinions from a recent price transparency congress on reporting, remediation, and ways to manage state price transparency now and in the future.
May 22, 2022
CMS Medicaid Copay Ruling
4 Minute Read
And other industry updates including the Medi-Cal older adult expansion and profiles of new pharmacy models and 3PLs entering the market.
April 28, 2022
Regulatory Market Updates, April 2022
3 Minute Read
We recap pressing issues from the past month, including the DUNS number transition, the latest in the Eli Lilly/Streck case, and rising healthcare spending for U.S. payers.
April 19, 2022
The Top 10 Market Access Challenges
5 Minute Read
We explore the 10 most common challenges facing Market Access operations, based on over 15 years of experience with more than 250 pharma manufacturers.